21 min listen
Behind the Buy: Payors and Providers on AI Adoption
FromRaising Health
ratings:
Length:
24 minutes
Released:
Mar 26, 2024
Format:
Podcast episode
Description
As any healthcare founder knows, it can be difficult to get into a room with the executives making purchase decisions for payors and providers—so we’re bringing the executives to you.This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you'll hear from the executives about how they're utilizing AI, the KPIs they use to gauge effectiveness, and what they consider a good partnership.Julie and Jay also authored an in-depth guide to commercializing AI in healthcare based on these interviews, available here. All of our go-to-market playbooks are available on our Digital Health Builders page.
Released:
Mar 26, 2024
Format:
Podcast episode
Titles in the series (100)
Journal Club: Turning a Toxin into a Genome Editing Tool: In this episode of Journal Club we discuss the development of the first genome editing enzyme capable of performing precision edits to the mitochondrial genome. Mutations in the mitochondrial genome cause over 150 different human diseases, but none of our existing gene editing tools have been able to edit this DNA. This newly developed tool can be used to create better models of these diseases and and perhaps one day be used to treat them with gene therapy. by Raising Health